Who really benefits from drug combinations and long titrations for pain? – Authors' reply

Tesfaye, S., Sloan, G., White, D. orcid.org/0000-0003-2871-7946 et al. (3 more authors) (2023) Who really benefits from drug combinations and long titrations for pain? – Authors' reply. The Lancet, 401 (10372). pp. 192-193. ISSN 0140-6736

Metadata

Authors/Creators:
Commentary on: Tesfaye, S., Sloan, G., Petrie, J. et al. (29 more authors) (2022) Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet, 400 (10353). pp. 680-690. ISSN 0140-6736
Copyright, Publisher and Additional Information: © 2023 Published by Elsevier Ltd. This is an author produced version of a paper subsequently published in The Lancet. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Humans; Pain; Drug Combinations
Dates:
  • Accepted: 19 December 2022
  • Published (online): 19 January 2023
  • Published: 21 January 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Funding Information:
FunderGrant number
NATIONAL INSTITUTE FOR HEALTH RESEARCHnan
NATIONAL INSTITUTE FOR HEALTH RESEARCH15/35/03
DEPARTMENT OF HEALTH AND SOCIAL CAREUNSPECIFIED
Depositing User: Symplectic Sheffield
Date Deposited: 03 Feb 2023 18:06
Last Modified: 19 Jul 2023 00:13
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/s0140-6736(23)00057-0
Related URLs:

Commentary/Response Threads

Export

Statistics